Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2005
04/19/2005US6881732 Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements
04/19/2005US6881731 Enhancers for microbiological disinfection
04/19/2005US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
04/19/2005US6881728 14-β, 17-α-hydroxymethylandrostane derivatives as androgens
04/19/2005US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/19/2005US6881726 Aqueous compositions containing metronidazole
04/19/2005US6881725 Administering to a subject a purine derivative to reduce traumatic pain, neuropathic pain, organ pain and pain associated with diseases
04/19/2005US6881724 Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
04/19/2005US6881719 Binding to immunoglobulins; analyzing
04/19/2005US6881575 Using fluorescent activated cell sorting to separate and isolate cells comprising mutations in cell proliferation; anticarcinogenic agents; antiproliferative agents
04/19/2005US6881553 Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
04/19/2005US6881548 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
04/19/2005US6881546 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
04/19/2005US6881426 Echinacea angustifolia extracts
04/19/2005US6881422 Drug for respiratory system disorders
04/19/2005US6881420 Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
04/19/2005US6881419 Vitamin formulation for enhancing bone strength
04/19/2005US6881417 Method, apparatus, and composition for automatically coating the human body with plural components
04/19/2005US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
04/19/2005US6881409 Compositions and methods for promoting nerve regeneration
04/19/2005US6881399 Cosmetic formulations of having high aqueous solubility and low flash points
04/19/2005US6881398 Therapeutic dry powder preparation
04/19/2005US6881397 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
04/19/2005US6881396 Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans
04/19/2005US6881208 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
04/19/2005US6880694 Method and apparatus for transferring substrates
04/19/2005CA2334155C Cyclic boroproline compounds
04/19/2005CA2315189C Integrin receptor antagonists
04/19/2005CA2295035C Pharmaceutical formulations containing voriconazole
04/19/2005CA2273894C Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
04/19/2005CA2172162C Optically active imidazolidinone derivative and process for producing the same
04/19/2005CA2150462C Syrup containing n-acetyl-cysteine
04/19/2005CA2138150C 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides
04/14/2005WO2005033661A2 Dmbt1 as a clinical marker and uses thereof
04/14/2005WO2005033331A1 Method for the identification of substances with prebiotic effect
04/14/2005WO2005033323A1 Process for producing 1,4-dihydoxy-2-naphthoic acid
04/14/2005WO2005033311A2 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis
04/14/2005WO2005033288A2 Hedgehog pathway antagonists
04/14/2005WO2005033279A2 Discovery of novel soluble crystalline anesthetics
04/14/2005WO2005033148A1 Hypo- and hyper-acetylated meningococcal capsular saccharides
04/14/2005WO2005033123A1 Stable vitamin b6 derivative
04/14/2005WO2005033113A2 Indole derivatives
04/14/2005WO2005033112A2 Substituted indole derivatives
04/14/2005WO2005033108A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
04/14/2005WO2005033107A1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
04/14/2005WO2005033105A2 Vanilloid receptor ligands and their use in treatments
04/14/2005WO2005033103A1 Quinoline compounds and their uses
04/14/2005WO2005033102A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
04/14/2005WO2005033099A2 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
04/14/2005WO2005033093A1 7,8-bicycloalkyl-chroman derivatives
04/14/2005WO2005033092A1 Chroman derivatives
04/14/2005WO2005033086A1 Compounds and compositions as protein kinase inhibitors
04/14/2005WO2005033079A1 Novel antifungal agent comprising heterocyclic compound
04/14/2005WO2005033078A1 Process for the production of atorvastatin calcium
04/14/2005WO2005033077A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes
04/14/2005WO2005033074A2 Salts and polymorphs of a potent antidiabetic compound
04/14/2005WO2005033073A2 Spirocyclic heterocyclic derivatives and methods of their use
04/14/2005WO2005033069A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
04/14/2005WO2005033068A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
04/14/2005WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators
04/14/2005WO2005033053A1 Process for producing product containing proanthocyanidin in high proportion
04/14/2005WO2005033049A2 METHOD OF PREPARING 4-AMINO-1H-IMIDAZO(4,5-c)QUINOLINES AND ACID ADDITION SALTS THEREOF
04/14/2005WO2005033048A2 Wnt pathway antagonists
04/14/2005WO2005033004A1 Methods and articles for maintaining hydantoinylated polymers in a biocidally active state
04/14/2005WO2005032597A1 Biodegradable polyacetals for in vivo polynucleotide delivery
04/14/2005WO2005032592A1 Hypnotic composition
04/14/2005WO2005032590A1 Remedy for diabetes
04/14/2005WO2005032588A1 Preparation containing basic drug
04/14/2005WO2005032580A1 Methods and compositions for treating eosinophil mediated gastro-intestinal dysfunction or disease
04/14/2005WO2005032572A2 Means and methods for the recruitment and identification of stem cells
04/14/2005WO2005032567A2 Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium
04/14/2005WO2005032563A1 Method for reducing vascular inflammation
04/14/2005WO2005032562A1 Methods for treating acute and overuse sprain and strain using hyaluronic acid
04/14/2005WO2005032561A1 INVENTION RELATING TO FUNCTION OF HIV-Vpr
04/14/2005WO2005032560A2 Biological action of optically active isomers of digoxin
04/14/2005WO2005032559A1 Nitric oxide donating derivatives for the treatment of cardiovascular disorders
04/14/2005WO2005032558A1 Extended triphasic contraceptive regimens
04/14/2005WO2005032557A1 Mycocide composition
04/14/2005WO2005032556A1 Method for reducing pain
04/14/2005WO2005032555A2 Pharmaceutical combinations of hydrocodone and naltrexone
04/14/2005WO2005032554A1 A novel transmucosal delivery system
04/14/2005WO2005032553A1 Composition for rapidly disintegrable tablet comprising amlodipine free base
04/14/2005WO2005032552A1 Hypnotic composition
04/14/2005WO2005032551A1 TREATMENT OF CARDIOVASCULAR DISEASE WITH INHIBITORS OF p38 KINASE
04/14/2005WO2005032549A1 Compositions and methods for treatment of fibrosis
04/14/2005WO2005032547A1 Bicyclo`3.1.1!heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors
04/14/2005WO2005032546A1 Hypnotic composition
04/14/2005WO2005032545A1 Composition for treating inflammatory bowel disease
04/14/2005WO2005032543A1 Hypnotic composition
04/14/2005WO2005032542A1 Neutralizing agent for cavitating toxin
04/14/2005WO2005032540A1 Remedy for respiratory diseases comprising n-(benzoyl)amino acid derivative as the active ingredient
04/14/2005WO2005032539A1 Alpha-linolenic acid and alpha-linolenic acid-containing vegetable oils used for combating diabetes
04/14/2005WO2005032538A1 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient
04/14/2005WO2005032537A1 Method for preventing and/or treating neurodegenerative diseases
04/14/2005WO2005032536A1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient
04/14/2005WO2005032535A1 Nerve regeneration promoters
04/14/2005WO2005032534A1 Ophthalmic composition for treating lacrimal disorders
04/14/2005WO2005032533A1 Novel association consisting of an anti-atherothrombotic agent and of a platelet antiaggregating agent
04/14/2005WO2005032532A1 Antimycotic composition
04/14/2005WO2005032531A1 Antimycotic composition
1 ... 4719 4720 4721 4722 4723 4724 4725 4726 4727 4728 4729 4730 4731 4732 4733 4734 4735 4736 4737 4738 4739 ... 7860